Purchase Order HHSPC200905705

The U.S. Office of the Director awarded a Blanket Purchase Agreement (BPA) call contract to Domestic Awardees (Undisclosed) on December 13, 2012, for the provision of drugs and biologicals with a ceiling value of $11,016.00. This firm fixed-price contract will be performed in Hercules, California, and carries an ultimate completion date of June 30, 2013. No set-aside designation was used in this award, indicating that the procurement was open to all eligible vendors. As a BPA call, this contract...

The U.S. civilian federal agency's Office of the Director awarded a Blanket Purchase Agreement (BPA) call valued at $5,762.72 to Domestic Awardees (Undisclosed) on October 31, 2012, for drugs and biologicals. This firm fixed-price contract, which was not subject to a set-aside designation, is scheduled for ultimate completion on June 30, 2013, with performance taking place in Hercules, California. The award represents a task order or call against an existing BPA vehicle, which provides an...

This federal contract award represents a Blanket Purchase Agreement (BPA) call issued by a civilian federal agency with an office of the director, issued to Domestic Awardees (Undisclosed) for drugs and biologicals. The contract was awarded on March 3, 2011, with a ceiling value of $3,315.00 and an ultimate completion date of April 30, 2011. The pricing structure is firm fixed price, and the work will be performed in Hercules, California. No set-aside designation was used for this procurement....

This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics to the agency in July 2025. The contract has no set-aside designation, indicating open competition. As a specialized pharmaceutical provider, Biologics, Inc. has a history of delivering critical medical treatments, particularly cancer medications, to...

<p>This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to Fleming and Company Pharmaceuticals, a pharmaceutical company. The contract is for the delivery of DRUGS AND BIOLOGICALS, with a ceiling value of $11,928,795.00. It is a firm fixed-price delivery order contract with a period of performance ending on March 16, 2010. The contract does not have a set-aside designation.</p>

This is a $20,432.27 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the emergency procurement of the cancer medication Lenalidomide. The contract has an ultimate completion date of September 30, 2025 and was awarded on August 21, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly...

This federal contract award is for the procurement of &quot;DRUGS AND BIOLOGICALS&quot; by the Office of the Director, a civilian federal agency. The $4,500.00 Firm Fixed Price contract was awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables that supports research, medical, forensic, and environmental initiatives for various federal agencies. The contract has no set-aside...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,224.96 contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML, a biologic drug used to treat autoimmune conditions. The contract has an ultimate completion date of May 13, 2024 and was awarded on May 10, 2024 without a set-aside designation. Dakota Drug,...

This is a firm-fixed-price Blanket Purchase Agreement (BPA) call contract awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, by the Office of the Director at a civilian federal agency. The contract is for &quot;DRUGS AND BIOLOGICALS&quot; with a ceiling value of $36,747.48 and an ultimate completion date of April 30, 2013. The contract does not have a set-aside designation. It appears to be part of a larger multi-award BPA with the Federal Bureau of...

This federal contract award was made by the Office of the Director to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $10,430.20 Firm Fixed Price contract is for the delivery of &quot;DRUGS AND BIOLOGICALS&quot; and was awarded on July 21, 2014, with an ultimate completion date of April 30, 2015. This contract was not set aside. Life Technologies Corporation, the prime contractor, is a...